CNBC Stock Blog
- Portfolio Prep for Next Week: 'Don't Get Crazy'
- Strategists on Dubai: Avoid 'Rash Moves' Now
- Dubai Stock Market Fear Has 'Legs': Dennis Gartman
- Surprising Options Trades in TiVo Shares
- 10 Dividend Picks For Your Portfolio: Chief Investors
- 4 Thanksgiving Week Buys For Your Portfolio: Market Pros
- There's a 'Great Chance' For a Double-Dip Recession: Strategist
- Retail Earnings and Sales to Improve in Q4: Analyst
- 4 Food Stocks to Stuff in Your Portfolio: Analyst
- S&P at 1050-1200 Trading Range Next Year: Strategist
- U.S. Stocks Fall on Dubai Worries
- Black Friday at Best Buy
- Strategists on Dubai: Avoid 'Rash Moves' Now
- Longer Lines, Fuller Carts This Black Friday
- Dubai Stock Market Fear Has 'Legs': Dennis Gartman
- Obama's Emission Reduction Pledge Paints Future for Autos
- Is Super Bowl Halftime Act Too Old?
- Surprising Options Trades in TiVo Shares
- EA Sports Hopes to Pump Up Sales Through Pop-Up Locations
- Dubai's Debt Woes Signal New Era for Creditors
- US Treasury Wants Banks to Do More to Ease Mortgages
- Fed Audit Would Hurt Economic Prospects: Bernanke
- Next Week: Cash In Now Or Wait For A Santa Rally?
- Dubai Stock Selloff May Bring Buying Opportunity
- Black Friday Sales Rise by 0.5%: ShopperTrak
- Longer Lines, Fuller Carts This Black Friday
- Big US Banks May Be Forced to Raise Capital: Bove
- Bank of America Amends Pay for Senior Executives
RSS FEED
writer, OptionMonster
Shares of Human Genome Sciences are up on the day Thursday and bringing in option traders.
HGSI stock [HGSI
Loading...
()
] is up more than 4 percent to $3.15 in early afternoon trading, well off the $3.44 high of the day that was reached just after the open. The shares have been strongly bullish since the low of just $0.45 back in March, putting the stock up more than 600 percent.
Today's options action focuses on the October expiration, where we see 4,100 of the October 5 calls purchased, the largest block for $0.80. OptionMonster's systems also show some of the October 2.50 calls sold, with one block of 1,000 going for $1.40, which will help offset the cost of the other calls bought by the same trader.
Options Trading School:
This is a clearly a longer-term bet that HGSI will climb back to levels seen last October, when the stock dropped from levels above $7 to below $2.50 in a month.
___________________________
Other Biopharma/Biotech Firms:
Amgen [AMGN
Loading...
()
]
Biogen Idec [BIIB
Loading...
()
]
Genzyme [GENZ
Loading...
()
]
Gilead Sciences [GILD
Loading...
()
]
___________________________
___________________________
Chris McKhann is an analyst and writer for OptionMonster.
___________________________








